These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 34724892)

  • 1. Correlation of MKI67 with prognosis, immune infiltration, and T cell exhaustion in hepatocellular carcinoma.
    Wu SY; Liao P; Yan LY; Zhao QY; Xie ZY; Dong J; Sun HT
    BMC Gastroenterol; 2021 Nov; 21(1):416. PubMed ID: 34724892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma.
    Wu SY; Xie ZY; Yan LY; Liu XF; Zhang Y; Wang DA; Dong J; Sun HT
    BMC Immunol; 2022 Jun; 23(1):28. PubMed ID: 35659256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Significance of
    Li Z; Cui Y; Duan Q; Zhang J; Shao D; Cao X; Gao Y; Wang S; Li J; Jones OD; Lei X; Wang L; Zhou X; Xu M; Ma J; Liu Y; Xu X
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DFNA5 regulates immune cells infiltration and exhaustion.
    Hu J; Pei W; Jiang M; Huang Y; Dong F; Jiang Z; Xu Y; Li Z
    Cancer Cell Int; 2022 Mar; 22(1):107. PubMed ID: 35248047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.
    Liu Z; Zhao P
    J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Single-cell and Transcriptome Sequencing Analyses Identified PREX1 as an Immune-related Prognostic Biomarker for Liver Hepatocellular Carcinoma.
    Yang J; Fan LY; Shi KY
    Int J Med Sci; 2024; 21(8):1559-1574. PubMed ID: 38903921
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
    Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDR1 is a Novel Biomarker and Potential Therapeutic Target for the Combination Treatment of Liver Hepatocellular Carcinoma.
    Li T; Hu H; Song Y; Shi Y; Hu D; Shen W; Ning B
    Cancer Control; 2024; 31():10732748241286257. PubMed ID: 39284684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target.
    Jiang Q; Kuai J; Jiang Z; Que W; Wang P; Huang W; Ding W; Zhong L
    Front Immunol; 2023; 14():1158360. PubMed ID: 37483608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration.
    Xu Y; Jiang Q; Liu H; Xiao X; Yang D; Saw PE; Luo B
    J Immunol Res; 2020; 2020():8835393. PubMed ID: 33490290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GADD45B predicts lung squamous cell carcinoma survival and impacts immune infiltration, and T cell exhaustion.
    Lv Y; Liu Z; Xiong K; Duan H; Yang J; Liao P
    Autoimmunity; 2023 Dec; 56(1):2209706. PubMed ID: 37165780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scinderin is a potential prognostic biomarker and correlated with immunological regulation: from pan-cancer analysis to liver hepatocellular carcinoma.
    Zhai S; Li Y; Yang Y; Lang W; Liu X; Liu K; Qu J; Zhu L
    Front Immunol; 2024; 15():1361657. PubMed ID: 39108273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the implication of steroid 5 alpha-reductase 3 on prognosis and immune microenvironment in Liver Hepatocellular Carcinoma.
    Lu Y; Liu Z; Zheng Y; Liu X; Liu X; Chen N; Mao K; Lin W
    Ann Med; 2024 Dec; 56(1):2408463. PubMed ID: 39340288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator of nonsense transcripts 3B is a prognostic biomarker and associated with immune cell infiltration in lung squamous cell and hepatocellular carcinoma.
    Li P; Zhou M; Gan X; Yuan C; Li G; Jin GN; Ding ZY
    Discov Oncol; 2024 Sep; 15(1):479. PubMed ID: 39331207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
    Jin W; Wang G; Dong M; Wang X
    Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
    Lin YR; Yang WJ; Yang GW
    Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma.
    Hou Y; Li J; Yu A; Deng K; Chen J; Wang Z; Huang L; Ma S; Dai X
    Int J Med Sci; 2023; 20(7):918-932. PubMed ID: 37324186
    [No Abstract]   [Full Text] [Related]  

  • 19. High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma.
    Xi G; Cheng R; Liang L; Che N; Wang Y; Zhao N; Liang X; Shao B; Zhao X; Zhang D
    Sci Rep; 2023 Apr; 13(1):6957. PubMed ID: 37117215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAC1 serves as a prognostic factor and correlated with immune infiltration in liver hepatocellular carcinoma.
    Li Y; Gu A; Yang L; Wang Q
    J Cancer Res Clin Oncol; 2024 Sep; 150(9):418. PubMed ID: 39264423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.